Clinically significant drug interactions
- PMID: 10750880
Clinically significant drug interactions
Abstract
A large number of drugs are introduced every year, and new interactions between medications are increasingly reported. Consequently, it is no longer practical for physicians to rely on memory alone to avoid potential drug interactions. Multiple drug regimens carry the risk of adverse interactions. Precipitant drugs modify the object drug's absorption, distribution, metabolism, excretion or actual clinical effect. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. Drugs with a narrow therapeutic range or low therapeutic index are more likely to be the objects for serious drug interactions. Object drugs in common use include warfarin, fluoroquinolones, antiepileptic drugs, oral contraceptives, cisapride and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Many other drugs, act as precipitants or objects, and a number of drugs act as both. Regularly updated manuals of drug interactions and CD-ROM-formatted programs are useful office references.
Comment in
-
Avoiding drug interactions.Am Fam Physician. 2000 Mar 15;61(6):1628, 1630, 1637. Am Fam Physician. 2000. PMID: 10750872 No abstract available.
Similar articles
-
Serious drug interactions.Practitioner. 1993 Oct;237(1531):789-91. Practitioner. 1993. PMID: 7903448 Review.
-
Drug interaction and pharmacist.J Young Pharm. 2010 Jul;2(3):326-31. doi: 10.4103/0975-1483.66807. J Young Pharm. 2010. PMID: 21042495 Free PMC article.
-
[Clinically significant" new drug interactions].Med Klin (Munich). 2000 May;95(1 Spec No):18-22. Med Klin (Munich). 2000. PMID: 10851844 Review. German.
-
Avoiding drug interactions.Prescrire Int. 2004 Jun;13(71):99-102. Prescrire Int. 2004. PMID: 15233147
-
Drug interactions.Am Fam Physician. 1983 Feb;27(2):229-38. Am Fam Physician. 1983. PMID: 6829378
Cited by
-
Effect of anti-tuberculosis therapy on polymorphic drug metabolizing enzyme CYP2C9 using phenytoin as a probe drug.Indian J Pharmacol. 2012 Jul-Aug;44(4):485-8. doi: 10.4103/0253-7613.99314. Indian J Pharmacol. 2012. PMID: 23087510 Free PMC article.
-
Potentially inappropriate medications and medication combinations before, during and after hospitalizations: an analysis of pathways and determinants in the Swiss healthcare setting.BMC Health Serv Res. 2021 May 28;21(1):522. doi: 10.1186/s12913-021-06550-w. BMC Health Serv Res. 2021. PMID: 34049550 Free PMC article.
-
Disparities in all-cause mortality with potentially inappropriate medication use: Analysis of the Reasons for Geographic and Racial Differences in Stroke study.J Am Pharm Assoc (2003). 2021 Jan-Feb;61(1):44-52. doi: 10.1016/j.japh.2020.08.041. Epub 2020 Sep 25. J Am Pharm Assoc (2003). 2021. PMID: 32988759 Free PMC article.
-
Drug Interactions in Neurocritical Care.Neurocrit Care. 2017 Oct;27(2):287-296. doi: 10.1007/s12028-016-0369-0. Neurocrit Care. 2017. PMID: 28054285 Review.
-
Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.Drugs Aging. 2010 Sep 1;27(9):759-70. doi: 10.2165/11538460-000000000-00000. Drugs Aging. 2010. PMID: 20809665
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical